A next generation of sclerostin inhibitor with bone anabolic potential and without increasing cardiovascular risk for osteogenesis imperfecta: How does sclerostin loop3-specific aptamer work?

Status	Active
Effective start/end date	1/01/22 → 30/06/24

Project Details